KRAS and pancreatic neoplasm: Recently, pancreatic cancer has been shown to undergo reprogramming in lipid-related and acetyl-CoA metabolism pathways [34,35,36], extending our finding about the importance of acetyl-CoA metabolism in romidepsin sensitivity in KRAS-activated cell lines.